Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Harnessing CD8+ T Cells Under HIV Antiretroviral Therapy.
Warren JA, Clutton G, Goonetilleke N. Warren JA, et al. Among authors: goonetilleke n. Front Immunol. 2019 Feb 26;10:291. doi: 10.3389/fimmu.2019.00291. eCollection 2019. Front Immunol. 2019. PMID: 30863403 Free PMC article. Review.
Reliable Estimation of CD8 T Cell Inhibition of In Vitro HIV-1 Replication.
Xu Y, Weideman AM, Abad-Fernandez M, Mollan KR, Kallon S, Samir S, Warren JA, Clutton G, Roan NR, Adimora AA, Archin N, Kuruc J, Gay C, Hudgens MG, Goonetilleke N. Xu Y, et al. Among authors: goonetilleke n. Front Immunol. 2021 Jun 30;12:666991. doi: 10.3389/fimmu.2021.666991. eCollection 2021. Front Immunol. 2021. PMID: 34276657 Free PMC article.
CD8 T Cell Virus Inhibition Assay Protocol.
Xu Y, Weideman AM, Abad-Fernandez M, Mollan KR, Kallon S, Samir S, Warren JA, Clutton G, Roan N, Adimora AA, Archin N, Kuruc J, Gay C, Hudgens MG, Goonetilleke N. Xu Y, et al. Among authors: goonetilleke n. Bio Protoc. 2022 Mar 20;12(6):e4354. doi: 10.21769/BioProtoc.4354. eCollection 2022 Mar 20. Bio Protoc. 2022. PMID: 35434196 Free PMC article.
HIV-Specific T Cell Responses Are Highly Stable on Antiretroviral Therapy.
Xu Y, Trumble IM, Warren JA, Clutton G, Abad-Fernandez M, Kirchnerr J, Adimora AA, Deeks SG, Margolis DM, Kuruc JD, Gay CL, Archin NM, Mollan KR, Hudgens M, Goonetilleke N. Xu Y, et al. Among authors: goonetilleke n. Mol Ther Methods Clin Dev. 2019 Aug 14;15:9-17. doi: 10.1016/j.omtm.2019.07.008. eCollection 2019 Dec 13. Mol Ther Methods Clin Dev. 2019. PMID: 31534983 Free PMC article.
Interval dosing with the HDAC inhibitor vorinostat effectively reverses HIV latency.
Archin NM, Kirchherr JL, Sung JA, Clutton G, Sholtis K, Xu Y, Allard B, Stuelke E, Kashuba AD, Kuruc JD, Eron J, Gay CL, Goonetilleke N, Margolis DM. Archin NM, et al. Among authors: goonetilleke n. J Clin Invest. 2017 Aug 1;127(8):3126-3135. doi: 10.1172/JCI92684. Epub 2017 Jul 17. J Clin Invest. 2017. PMID: 28714868 Free PMC article.
Assessing the impact of AGS-004, a dendritic cell-based immunotherapy, and vorinostat on persistent HIV-1 Infection.
Gay CL, Kuruc JD, Falcinelli SD, Warren JA, Reifeis SA, Kirchherr JL, James KS, Dewey MG, Helms A, Allard B, Stuelke E, Gamble A, Plachco A, Gorelick RJ, Eron JJ, Hudgens M, Garrido C, Goonetilleke N, DeBenedette MA, Tcherepanova IY, Nicolette CA, Archin NM, Margolis DM. Gay CL, et al. Among authors: goonetilleke n. Sci Rep. 2020 Mar 20;10(1):5134. doi: 10.1038/s41598-020-61878-3. Sci Rep. 2020. PMID: 32198428 Free PMC article.
86 results